NCT06636201 Large-scale Multi-omics Analysis of Cerebrospinal Fluid
| NCT ID | NCT06636201 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Second Affiliated Hospital, School of Medicine, Zhejiang University |
| Condition | Aging |
| Study Type | OBSERVATIONAL |
| Enrollment | 150 participants |
| Start Date | 2024-03-01 |
| Primary Completion | 2025-03-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 150 participants in total. It began in 2024-03-01 with a primary completion date of 2025-03-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to explore the role of cerebrospinal fluid (CSF) biomarkers in aging and neurodegenerative diseases.
Eligibility Criteria
1. Inclusion Criteria: * Patients aged 0 to 90 years will be selected for the study. * Patients admitted for surgery under spinal anesthesia due to non-neurological conditions, such as lower limb fractures or hemorrhoids. * Pediatric patients undergoing surgical treatment for tethered spinal cord syndrome. 2. Exclusion Criteria: * Patients with neurological conditions, including encephalitis, Parkinson's disease, Alzheimer's disease, hydrocephalus, brain tumors, and psychiatric disorders.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06636201 clinical trial?
This trial is open to participants of all sexes, aged 0 Years or older, up to 90 Years, studying Aging. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06636201 currently recruiting?
Yes, NCT06636201 is actively recruiting participants. Contact the research team at dr.zhujunming@zju.edu.cn for enrollment information.
Where is the NCT06636201 trial being conducted?
This trial is being conducted at Hangzhou, China.
Who is sponsoring the NCT06636201 clinical trial?
NCT06636201 is sponsored by Second Affiliated Hospital, School of Medicine, Zhejiang University. The trial plans to enroll 150 participants.